New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study
PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in patients with inflammatory bowel disease who have ulcerative colitis. The lack of effective drugs forces patients to undergo liver transplantation, because 50 percent of them will require this procedure between 10 to 18 years after their initial diagnosis
PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in patients with inflammatory bowel disease who have ulcerative colitis. The lack of effective drugs forces patients to undergo liver transplantation, because 50 percent of them will require this procedure between 10 to 18 years after their initial diagnosis
